The measurement of placental thickness can effectively differentiate normal
pregnancies from affected pregnancies requiring invasive work-up.
The objective was to evaluate the efficacy of placental thickness at mid-pr
egnancy in predicting fetal Hb Bart's disease in pregnancies at risk.
Among 17 254 pregnant women screened for severe thalassaemia between June 1
994 and December 1998, 345 pregnancies at risk for having a fetus with Hb B
art's disease underwent ultrasound examinations and cordocentesis at 18-21
gestational weeks. Before cordocentesis, the placental thickness was measur
ed and recorded. The definite fetal diagnosis was performed with high perfo
rmance liquid chromatography. The efficacy of placental thickness in predic
ting Hb Bart's disease was evaluated by sensitivity and specificity. Variou
s cut-off values of the placental thickness were used for calculation and t
he best cut-off value was determined by a receiver-operating characteristic
(ROC) curve.
Of 345 pregnancies at risk, 70 fetuses with Hb Bart's disease were finally
diagnosed. The mean placental thickness (+/- SD) of the normal pregnancies
and pregnancies with Hb Bart's fetuses were significantly different, 24.6 /- 5.2 mm and 34.5 +/- 6.7 mm, respectively (Student's t-test, p < 0.001).
The sensitivity and specificity of placental thickness in prediction were c
alculated for various cut-off values. Based on the ROC curve? the best cut-
off value was 30 mm (> 30 mm considered abnormal), giving a sensitivity of
88.57 per cent, specificity of 90.18 per cent, positive-predictive value of
78.48 per cent and negative-predictive value of 96.87 per cent.
For couples at risk, when sonographic placental thickness is normal, the ri
sk of having an Hb Bart's fetus is markedly decreased. The measurement of p
lacental thickness can effectively, though not absolutely, differentiate th
e normal pregnancies from affected ones requiring invasive work-up. (C) 199
9 John Wiley & Sons, Ltd.